Article
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice
2026-05-15
Abstract excerpt
Retrospective studies in patients with non-muscle invasive bladder cancer (NMIBC) have reported a significant reduction in Alzheimer’s disease (AD) incidence (12–78%) among Bacillus Calmette-Guérin (BCG) recipients versus controls. To investigate the underlying mechanisms, we evaluated BCG in the PS19 mouse model of tauopathy. We found that BCG administration reduced hippocampal phospho–tau and microgliosis while...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a43e467b-c1fe-562a-9f31-54303479a335
- DOI
- 10.64898/2026.05.12.724591
